Eating mushrooms may reduce the risk of cognitive impairment, writes Nicholas Bakalar in the New York Times March 14, 2019.
Researchers in Singapore used data on 663 Chinese men and women over 60. In one-on-one interviews, they recorded diet information, including questions about six types of commonly consumed mushrooms. They assessed cognitive function with detailed structured interviews and widely used tests of mental acuity.
After controlling for many health, behavioral and socioeconomic factors, including the consumption of meat, green vegetables, fruits and nuts, they found that compared with those who consumed less than one five-ounce portion of mushrooms a week, those who consumed one to two portions had a 43 percent reduced risk for M.C.I. People who ate more than two portions had a 52 percent reduced risk. The study is in the Journal of Alzheimer’s Disease.
The reasons for the association are not clear, but mushrooms contain various antioxidants that may inhibit the buildup in the brain of amyloid beta and tau, proteins that are hallmarks of Alzheimer’s disease.
Donald Abrams, MD, described the health benefits of mushrooms in “Cancer & Nutrition” (O’Shaughnessy’s Autumn 2011). Uncooked white button mushrooms —commonly sliced into salads— contain a possible carcinogen, Abrams warned:
Shiitake mushrooms are enjoyed in Asia for their immune-enhancing, antitumor and antiviral, and general antibiotic properties. They are rich in amino acids and fiber and are a good source of vitamins, particularly B12 and ergosterol, which is converted by sunlight into vitamin D. Shiitakes also contain an antitumor polysaccharide known as lentinan, which triggers lymphokines, interferon, and interleukin. This cascade augments natural killer-cell function.
Shiitake, maitake, and enoki mushrooms and their constituents are often used concurrently with chemotherapy and radiation in Japan as adjuvant therapies.
All edible mushrooms must be cooked to break down cell walls to make beneficial nutrients more accessible. White button mushrooms (Agaricus bisporus), commonly sliced raw and tossed into salads, contain agaritine, which is related to hydrazine, which is a carcinogen (mostly inactivated with cooking). There is some suggestion that the Agaricus species (white buttons, cremini, and portobello mushrooms) may contain an aromatase inhibitor-like activity.
Dr. Abrams adds in an email 3/19/19: “Paul Stamets doesn’t even eat cooked buttons!”
In 2015, researchers at the University of Michigan published the first systematic comparison among medical cannabis users who use and do not use prescription pain medications (PPMs). PPM users and nonusers did not exhibit any difference in either lifetime or past-3-month use of other drugs, including cocaine, sedatives, street opioids, and amphetamines. PPM users rated the efficacy of cannabis higher than PPM for pain management and indicated a strong desire to reduce PPM usage. Longitudinal study designs are needed to better understand the trajectories of alcohol and other drug involvement over time among medical cannabis users. 
In the United States, post traumatic stress disorder (PTSD) is diagnosed in approximately 5.2 million people annually, and these people suffer a wide range of symptoms. A comprehensive literature search on PTSD and cannabis covering the period January 1, 1995, to October 1, 2014 was conducted. While further research into cannabinoid treatment effects on PTSD symptoms is required, the evaluated evidence indicates that substantial numbers of military veterans with PTSD use cannabis or derivative products to control PTSD symptoms, with some patients reporting benefits in terms of reduced anxiety and insomnia and improved coping ability.